Adult Infectious Diseases Fellowship
Saudi Fellowship Final Written Examination - Adult Infectious Diseases (SCFHS)
Viral DiseasesEnglish
Exam overviewPractice session
A 27-year-old man is newly diagnosed with HIV-1 infection during routine screening. His baseline CD4 count is 410 cells/mcL, HIV-1 RNA is 85,000 copies/mL, and serum creatinine is 0.9 mg/dL. Genotypic resistance testing and HLA-B*5701 testing are sent. He is eager to start antiretroviral therapy (ART) today. According to current DHHS and WHO guidelines, which of the following regimens represents the preferred first-line ART regimen with a high genetic barrier to resistance that can be safely initiated prior to receiving resistance and HLA-B*5701 test results?
Loading your practice session…